PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

1800PetMeds provides pet health products and medications. The website claims to be a trusted expert in pet health.

Metric
Company Name	PetMed Express, Inc.
Symbol	PETS
MSH ID	COM:1800PETMEDS
Market	STOCKS
Sector	Healthcare
Industry	Medical - Pharmaceuticals
Country	US
Stage
Employee Count	287
Website	petmeds.com
LinkedIn
Founders

Metric
Market Cap	97.12M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	281.06M
Revenue (LTM)
Revenue (NTM)
Gross Profit	71.59M
EBITDA	94K
Operating Income	-6.96M
Net Income	-7.46M
EPS	-0.37
Diluted EPS	-0.37
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.28
Operating Profit Margin	-0.01
EBITDA Margin	0.00
Net Profit Margin	-0.01
Return on Equity	-0.03
Return on Assets	-0.02
Return on Capital Employed	-0.02

COM:1800PETMEDS

1800PetMeds

Last Close

4.64

22/11 21:00

Market Cap

75.63M

Beta: -

Volume Today

144.89K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-20.21
P/B Ratio	1.08
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.37
EV Multiple	26.71

Metric
Days Sales Outstanding	2.93
Days Payables Outstanding	47.43
Days Inventory Outstanding	63.08
Operating Cycle	65.62
Cash Conversion Cycle	4.96
Asset Turnover	2.10

Metric
Operating Cash Flow	4.32M
Free Cash Flow	-194K
Cash Flow to Debt	12.24
Operating Cash Flow/Sales	0.08
Free Cash Flow Yield	0.14

Metric
Cash & Equivalents	55.30M
Accounts Receivable	-1.74M
Inventory	28.56M
Goodwill
Debt to Capitalization	0.02
Debt to Assets	0.01
Current Ratio	2.10
Quick Ratio	1.37

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03
R&D to Revenue
SG&A to Revenue	0.22